Previous 10 | Next 10 |
Ampio Pharmaceuticals, Inc. Provides Business Update and Reports Third Quarter 2020 Financial Results PR Newswire ENGLEWOOD, Colo., Nov. 5, 2020 ENGLEWOOD, Colo. , Nov. 5, 2020 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceuti...
Ampio Pharmaceuticals, Inc. to Host Conference Call on November 5th Will Provide Business Update and Review Third Quarter Financial Results PR Newswire ENGLEWOOD, Colo., Nov. 2, 2020 ENGLEWOOD, Colo. , Nov. 2, 2020 /PRNewswire/ -- Ampio Pharmaceuticals (N...
Ampio Pharmaceuticals (AMPE) rises 5% in premarket on moderately higher volume, after it commenced recruiting and enrolling patients in a Phase 1 trial to evaluate inhaled Ampion added to the standard of care ((SOC)) for COVID-19 infected patients hospitalized for res...
Ampio Begins Phase 1 Clinical Trial of Inhaled Ampion For COVID-19 Patients With Respiratory Distress PR Newswire ENGLEWOOD, Colo., Oct. 28, 2020 ENGLEWOOD, Colo. , Oct. 28, 2020 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a b...
Ampio Pharmaceuticals, Inc. to Present at the ROTH Capital Healthcare Event "COVID-19 Therapeutics in Development" PR Newswire ENGLEWOOD, Colo., Oct. 27, 2020 ENGLEWOOD, Colo. , Oct. 27, 2020 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AM...
Ampio Presents at Roth Capital Partners 2020 MedTech Innovation Forum Focusing on COVID-19 Clinical Trial Activities PR Newswire ENGLEWOOD, Colo., Oct. 26, 2020 ENGLEWOOD, Colo. , Oct. 26, 2020 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American:...
Ampio Publication Reports Beneficial Effects of Ampion on Important Transcription Factors in Inflammation PR Newswire ENGLEWOOD, Colo., Oct. 8, 2020 ENGLEWOOD, Colo. , Oct. 8, 2020 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biop...
Ampio Pharmaceuticals (AMPE) -6%.Tesla (TSLA) -5% after Elon Musk tweeted "what we announce will not reach serious high-volume production until 2022" ahead of Battery Day Event. For further details see: AMPE, TSLA among premarket losers
Ampio Pharmaceuticals (AMPE) soars 28% premarket after receiving an an Investigational New Drug ((IND)) from the FDA, allowing the Company to proceed with clinical trials for the use of Ampion as an inhalation therapy for respiratory distress due to COVID-19 infection. Phase I ...
FDA Grants IND and Approves Clinical Trial Protocol of Inhaled Ampion for COVID-19 Patients with Respiratory Distress PR Newswire ENGLEWOOD, Colo., Sept. 21, 2020 ENGLEWOOD, Colo. , Sept. 21, 2020 /PRNewswire/ — Ampio Pharmaceuticals, Inc. (N...
News, Short Squeeze, Breakout and More Instantly...
Ampio Pharmaceuticals Inc. Company Name:
AMPE Stock Symbol:
OTCMKTS Market:
Ampio Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Next.e.GO N.V. (EGOX) rose 94.4% to $0.07 on volume of 92,836,985 shares AGBA Group Holding Limited (AGBA) rose 46.1% to $1.505 on volume of 55,502,222 shares PROSHARES TRUST (SQQQ) rose 1.2% to $12.2099 on volume of 25,933,897 shares...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 7.2% to $0.04 on volume of 426,309,096 shares PROSHARES TRUST (SQQQ) rose 1.8% to $12.07 on volume of 171,048,374 shares AGBA Group Holding Limited (AGBA) rose 157.5% to $1.03 on volume of 121,894,6...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 73.2% to $0.0646 on volume of 191,555,690 shares AGBA Group Holding Limited (AGBA) rose 245.0% to $1.38 on volume of 41,065,125 shares TIAN RUIXIANG Holdings Ltd (TIRX) rose 135.2% to $1.14 on volum...